Gene therapy of malignant glioma: recent advances in experimental and clinical studies (Q45890411)

17 December 2017

review article

1 reference

title

Gene therapy of malignant glioma: recent advances in experimental and clinical studies (English)

1 reference

17 December 2017

0 references

M Sasaki

1

1 reference

17 December 2017

K H Plate

series ordinal

2

1 reference

17 December 2017

publication date

1 November 1998

1 reference

17 December 2017

published in

Annals of Oncology

1 reference

17 December 2017

volume

9

1 reference

17 December 2017

issue

11

1 reference

17 December 2017

page(s)

1155-1166

1 reference

17 December 2017

Long-term survival in patients with malignant astrocytoma

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

The ADA human gene therapy clinical protocol: Points to Consider response with clinical protocol, July 6, 1990.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Gene therapy in the United States: a five-year status report

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Influence of PGE2- and cAMP-modulating agents on human glioblastoma cell killing by interleukin-2-activated lymphocytes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Modulation of T-cell function by gliomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Regression of experimental brain tumors with 6-thioxanthine and Escherichia coli gpt gene therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Targeting of an inducible toxic phenotype in animal cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Bystander tumoricidal effect in the treatment of experimental brain tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Thymidine kinase-mediated killing of rat brain tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Adenovirus-mediated gene therapy of experimental gliomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Trans receptor inhibition of human glioblastoma cells by erbB family ectodomains.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Application of antisense ribonucleic acid complementary to O6-methylguanine-deoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Specific inhibition of c-sis protein synthesis and cell proliferation with antisense oligodeoxynucleotides in human glioma cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Transfection with bFGF sense and antisense cDNA resulting in modification of malignant glioma growth

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Gene therapy of malignant glioma via inhibition of tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

An experimental model of retrovirus gene therapy for malignant brain tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Intrathecal gene therapy for the treatment of leptomeningeal carcinomatosis. GTI 0108. A phase I/II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Treatment of leptomeningeal metastases in a rat model using a recombinant adenovirus containing the HSV-tk gene

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Cellular and molecular neurosurgery: pathways from concept to reality--part II: vector systems and delivery methodologies for gene therapy of the central nervous system

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Isolation, Characterization, and use of Stem Cells from the CNS

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Repair of demyelinated lesions by transplantation of purified 0-2A progenitor cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Macrophages in experimental and human brain tumors. Part 1: Studies of the macrophage content of experimental rat brain tumors of varying immunogenicity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008488709359

7 January 2021

Identifiers

DOI

10.1023/A:1008488709359

1 reference

17 December 2017

1 reference

17 December 2017